PLoS ONE (Jan 2019)

Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals.

  • Livia Melo Villar,
  • Bruno Geloneze,
  • Ana Carolina Junqueira Vasques,
  • Maria Lucia Elias Pires,
  • Juliana Custódio Miguel,
  • Elisangela Ferreira da Silva,
  • Vanessa Alves Marques,
  • Leticia de Paula Scalioni,
  • Elisabeth Lampe

DOI
https://doi.org/10.1371/journal.pone.0211193
Journal volume & issue
Vol. 14, no. 2
p. e0211193

Abstract

Read online

Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, like hepatitis B or C virus. This study aims to determine HBV and HCV infection prevalence in DM2 patients from Northeast and Southeast Brazil. A total of 537 DM2 patients were included, 194 (36.12%) males and 343 (63.87%) females, with mean age of 57.13±11.49 years. HBV and HCV markers were determined using serological and molecular analysis, and risk factors were evaluated in a subgroup from Southeast (n = 84). Two HBV acute (HBsAg+/anti-HBc -) and one HBV chronic case (HBsAg+/anti-HBc+) were found. Six individuals (1.1%) were isolated anti-HBc, 37 (6.9%) had HBV infection resolved (anti-HBc+/anti-HBs+), 40 (7.4%) were considered HBV vaccinated (anti-HBc-/anti-HBs+). Thirteen patients (2.42%) had anti-HCV and 7 of them were HCV RNA+. In the subgroup, anti-HBc positivity was associated to age and anti-HCV positivity was associated to age, time of diabetes diagnosis, total bilirubin, indirect bilirubin, alkaline phosphatase at bivariate analysis, but none of them was statistically significant at multivariate analysis. As conclusion, low prevalence of HBV and high prevalence HCV was found in DM2 patients.